Drugs Made In America Acquisition II Corp. - Ordinary Shares (DMII)
Stock listed on Nasdaq Stock Market (NASDAQ) · Blank Checks · prices in USD
Price
10.19 USD0.00 (0.00%)Close on (end-of-day, stored)
Key statistics · as of Oct 23, 2026
- 52-week range
- 9.86 – 10.33
- Market cap
- 649.1M USD
- P/E
- —
- P/B
- −36.2
- EV/EBITDA
- —
- Dividend yield
- —
- 1-year return
- —
- 3-month return
- +0.8%
- Volatility (1y)
- 1.8%
- Max drawdown (1y)
- −0.7%
- Beta (1y)
- −0.01
- RSI (14)
- 60
- Revenue growth
- —
- ROE
- —
- ROIC
- —
- Debt / equity
- —
Ratios are calculated by AlphaScope from stored prices and reported financial statements; see the methodology. Blank values mean the data is not available.
Financial statements · annual · USD
| Fiscal year ending | Dec 31, 2025 |
|---|---|
| Operating income | -488.4K |
| Net income | 4.2M |
| Total assets | 505M |
| Total liabilities | 17.8M |
| Shareholders’ equity | -17.8M |
| Operating cash flow | -1M |
Source: SEC EDGAR companyfacts. Full income statement, balance sheet and cash flow, quarterly and trailing-twelve-month views are in the app.
Peers · Blank Checks
DMII news
No stored headlines.